In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program

This letter to the editor responds to the letter from Su et al, regarding concerns related to immortal time bias that may partially account for recently published study results.

Detalles Bibliográficos
Autores principales: Hao, Zhonglin, Chen, Quan, Huang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322135/
https://www.ncbi.nlm.nih.gov/pubmed/37210565
http://dx.doi.org/10.1093/oncolo/oyad133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322135/
https://www.ncbi.nlm.nih.gov/pubmed/37210565
http://dx.doi.org/10.1093/oncolo/oyad133

Ejemplares similares